Y. Claustre

发表

Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.

K. Chergui, F. Gonon, H. Schoemaker, 1997, The Journal of pharmacology and experimental therapeutics.

The preclinical pharmacologic profile of tiapride

G. Perrault, D. Sanger, H. Schoemaker, 2001, European Psychiatry.

Substituted tetrahydro-beta-carbolines are possible candidates as endogenous ligand of the [3H]imipramine recognition site.

Y. Claustre, B. Scatton, C. R. Lee, 1984, European journal of pharmacology.

Discriminative Stimulus Effects of Drugs Acting at GABAA Receptors Differential Profiles and Receptor Selectivity

G. Perrault, D. Sanger, H. Schoemaker, 1999, Pharmacology Biochemistry and Behavior.

Muscarinic Receptor‐Mediated Increase in Extracellular Inositol 1,4,5‐Trisphosphate Levels in the Rat Hippocampus: An In Vivo Microdialysis Study

Y. Claustre, L. Rouquier, J. Bénavidès, 1994, Journal of neurochemistry.

Fengabine, a novel antidepressant GABAergic agent. II. Effect on cerebral noradrenergic, serotonergic and GABAergic transmission in the rat.

Y. Claustre, B. Scatton, K. Lloyd, 1987, The Journal of pharmacology and experimental therapeutics.

In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.

H. Schoemaker, Y. Claustre, J. Bénavidès, 1995, Arzneimittel-Forschung.

SL 81.0385: A novel selective and potent serotonin uptake inhibitor

H. Schoemaker, Y. Claustre, B. Scatton, 1988 .

L-glutamate increases internal free calcium levels in synaptoneurosomes from immature rat brain via quisqualate receptors

Y. Claustre, J. Bénavidès, B. Scatton, 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

Pharmacological studies on stress-induced increase in frontal cortical dopamine metabolism in the rat.

Y. Claustre, B. Scatton, T. Dennis, 1986, The Journal of pharmacology and experimental therapeutics.

Potential Mechanisms Involved in the Negative Coupling Between Serotonin 5‐HT1A Receptors and Carbachol‐Stimulated Phosphoinositide Turnover in the Rat Hippocampus

Y. Claustre, J. Bénavidès, B. Scatton, 1991, Journal of neurochemistry.

Characterization of [3H]paroxetine binding to rat cortical membranes.

Y. Claustre, S. Z. Langer, D. Graham, 1985, European journal of pharmacology.

SSR180575 (7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair.

P. Soubrié, M. Schumacher, Y. Claustre, 2002, The Journal of pharmacology and experimental therapeutics.

Effects of the β3-adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent: Relevance to its antidepressant/anxiolytic-like profile

Y. Claustre, L. Rouquier, B. Scatton, 2008, Neuroscience.

SSR181507, A Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist. I: Neurochemical and Electrophysiological Profile

H. Schoemaker, P. Soubrié, Y. Claustre, 2003, Neuropsychopharmacology.

Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.

Y. Claustre, D. Fage, B. Scatton, 1985, The Journal of pharmacology and experimental therapeutics.

Pharmacological characterization of serotonin-stimulated phosphoinositide turnover in brain regions of the immature rat.

Y. Claustre, L. Rouquier, B. Scatton, 1988, The Journal of pharmacology and experimental therapeutics.

Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain

Gilles Bonvento, G. Bonvento, Y. Claustre, 1992, Neuroscience Letters.

Effect of the putative 5-HT1A receptor antagonist NAN-190 on rat brain serotonergic transmission.

Y. Claustre, L. Rouquier, B. Scatton, 1991, European journal of pharmacology.

Activation of 5-HT1A receptors inhibits carbachol-stimulated inositol 1,4,5-trisphosphate mass accumulation in the rodent hippocampus

Y. Claustre, C. Minisclou, J. Benavides, 1995, Neurochemical Research.

Alpha 1-adrenoceptor antagonists differentially control serotonin release in the hippocampus and striatum: a microdialysis study.

Y. Claustre, L. Rouquier, J. Benavides, 1994, European journal of pharmacology.

5-HT1A receptor agonists inhibit carbachol-induced stimulation of phosphoinositide turnover in the rat hippocampus.

Y. Claustre, B. Scatton, J. Benavides, 1988, European journal of pharmacology.

Anorectic activities of serotonin uptake inhibitors: correlation with their potencies at inhibiting serotonin uptake in vivo and 3H-mazindol binding in vitro.

Y. Claustre, B. Scatton, S. Z. Langer, 1988, Life sciences.

Alterations of noradrenaline and serotonin uptake and metabolism in chronic cobalt-induced epilepsy in the rat

S. Trottier, P. Chauvel, J. Caboche, 1983, Brain Research.

Recent findings in central dopaminergic and cholinergic neurotransmission of roman high- and low-avoidance (RHA/Verh and RLA/Verh) rats

Y. Claustre, D. Fage, B. Scatton, 1987, Behavioural Brain Research.

SL 85.0324: a novel benzimidazole derivative with selective histamine H1-receptor antagonist properties

H. Schoemaker, Y. Claustre, B. Scatton, 1990 .

Amisulpride: from animal pharmacology to therapeutic action

G. Perrault, D. Sanger, H. Schoemaker, 1997, International clinical psychopharmacology.

Effects of the vasopressin (V1B) receptor antagonist, SSR149415, and the corticotropin-releasing factor 1 receptor antagonist, SSR125543, on FG 7142-induced increase in acetylcholine and norepinephrine release in the rat

Y. Claustre, L. Rouquier, R. Steinberg, 2006, Neuroscience.

5-HT1C receptors mediate phosphoinositide turnover activation in the immature rat hippocampus.

Y. Claustre, B. Scatton, B. Eudeline, 1992, European journal of pharmacology.